Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours.
The diagnostic work-up and treatment of patients with neuroendocrine tumours has undergone a major change during the last decade. New diagnostic possibilities and treatment options have been developed. These Nordic guidelines, written by a group with a major interest in the subject, summarises our current view on how to diagnose and treat these patients. The guidelines are meant to be useful in the daily practice for clinicians handling patients with neuroendocrine tumours.
Janson
Eva Tiensuu
ET
Department of Medical Sciences, Uppsala University, Uppsala, Sweden. Tiensuu_Janson@medsci.uu.se
Sørbye
Halfdan
H
Welin
Staffan
S
Federspiel
Birgitte
B
Grønbaek
Henning
H
Hellman
Per
P
Mathisen
Oystein
O
Mortensen
Jann
J
Sundin
Anders
A
Thiis-Evensen
Espen
E
Välimäki
Matti J
MJ
Oberg
Kjell
K
Knigge
Ulrich
U
D000465:Algorithms; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000378:metabolism; D017024:Chemotherapy, Adjuvant; D003718:Denmark; D005387:Finland; D005770:Gastrointestinal Neoplasms / Q000145:classification / Q000175:diagnosis* / Q000628:therapy*; D006801:Humans; D018358:Neuroendocrine Tumors / Q000145:classification / Q000175:diagnosis* / Q000628:therapy*; D009664:Norway; D010190:Pancreatic Neoplasms / Q000145:classification / Q000175:diagnosis* / Q000628:therapy*; D018714:Radiotherapy, Adjuvant; D013548:Sweden
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor